| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000272449.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.014489979 |
Resistant |
| ENSG00000272449.1 |
Gefitinib |
Esophageal cancer |
0.024943351 |
Resistant |
| ENSG00000272449.1 |
Gefitinib |
Thyroid carcinoma |
0.006533064 |
Sensitive |
